Similar articles

• Nonsteroidal anti-inflammatories (NSAIDS), oral hypoglycemics, and topical steroids. An overview.

  Guadara J, Guadara D. Guadara J, et al. Clin Podiatr Med Surg. 1998 Oct;15(4):687-703, vi. Clin Podiatr Med Surg. 1998. PMID: 9917986 Review.
• [Item 174--Prescription and surveillance of steroidal and non-steroidal anti-inflammatory agents].

  CEDEF. CEDEF. Ann Dermatol Venereol. 2012 Oct;139(11 Suppl):A167-71. doi: 10.1016/j.annder.2012.06.016. Epub 2012 Jul 24. Ann Dermatol Venereol. 2012. PMID: 23176841 French. No abstract available.
• [Item no 174: prescription and surveillance of steroidal and non-steroidal anti-inflammatory agents].

  CEDEF. CEDEF. Ann Dermatol Venereol. 2008 Nov;135(11 Suppl):F163-7. doi: 10.1016/j.annder.2008.07.034. Ann Dermatol Venereol. 2008. PMID: 18984208 French. No abstract available.
• [Dermatologic topical corticosteroids. Principles and usage standards, posology].

  [No authors listed] [No authors listed] Ann Dermatol Venereol. 2000 Oct;127(Spec No 1):A180-5. Ann Dermatol Venereol. 2000. PMID: 11474520 French. No abstract available.
• Topical steroid treatment in infants, children, and adolescents.

  Hepburn D, Yohn JJ, Weston WL. Hepburn D, et al. Adv Dermatol. 1994;9:225-54; discussion 255. Adv Dermatol. 1994. PMID: 8060739 Review. No abstract available.